Winnergy Medical PCL
SET:WINMED
Income Statement
Earnings Waterfall
Winnergy Medical PCL
Income Statement
Winnergy Medical PCL
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
9
|
8
|
8
|
9
|
8
|
6
|
5
|
4
|
5
|
6
|
7
|
8
|
7
|
8
|
9
|
10
|
12
|
13
|
12
|
13
|
14
|
|
| Revenue |
527
N/A
|
544
+3%
|
531
-3%
|
518
-2%
|
520
+0%
|
521
+0%
|
539
+3%
|
577
+7%
|
652
+13%
|
685
+5%
|
703
+3%
|
685
-3%
|
654
-4%
|
667
+2%
|
639
-4%
|
641
+0%
|
621
-3%
|
619
0%
|
654
+6%
|
672
+3%
|
682
+1%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(273)
|
(284)
|
(283)
|
(276)
|
(279)
|
(280)
|
(295)
|
(336)
|
(402)
|
(437)
|
(442)
|
(417)
|
(381)
|
(380)
|
(378)
|
(381)
|
(377)
|
(375)
|
(386)
|
(396)
|
(396)
|
|
| Gross Profit |
254
N/A
|
260
+2%
|
247
-5%
|
242
-2%
|
242
0%
|
240
-1%
|
243
+1%
|
240
-1%
|
250
+4%
|
248
-1%
|
262
+6%
|
268
+2%
|
274
+2%
|
286
+5%
|
261
-9%
|
260
0%
|
244
-6%
|
193
-21%
|
268
+39%
|
225
-16%
|
286
+27%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(182)
|
(182)
|
(177)
|
(171)
|
(176)
|
(168)
|
(166)
|
(162)
|
(159)
|
(170)
|
(185)
|
(198)
|
(214)
|
(233)
|
(223)
|
(218)
|
(203)
|
(200)
|
(243)
|
(225)
|
(234)
|
|
| Selling, General & Administrative |
(184)
|
(184)
|
(178)
|
(172)
|
(179)
|
(183)
|
(186)
|
(189)
|
(195)
|
(193)
|
(204)
|
(210)
|
(217)
|
(239)
|
(227)
|
(229)
|
(222)
|
(221)
|
(244)
|
(250)
|
(254)
|
|
| Other Operating Expenses |
2
|
2
|
1
|
1
|
3
|
15
|
20
|
27
|
35
|
24
|
18
|
12
|
2
|
5
|
4
|
11
|
19
|
21
|
1
|
25
|
20
|
|
| Operating Income |
71
N/A
|
78
+10%
|
70
-11%
|
71
+1%
|
66
-7%
|
72
+9%
|
77
+7%
|
78
+1%
|
91
+16%
|
78
-14%
|
76
-2%
|
70
-8%
|
59
-16%
|
53
-10%
|
38
-28%
|
42
+11%
|
41
-3%
|
45
+9%
|
26
-43%
|
51
+98%
|
51
+1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(9)
|
(8)
|
(8)
|
(9)
|
(8)
|
(6)
|
(5)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(7)
|
(8)
|
(4)
|
(10)
|
0
|
(9)
|
(8)
|
(10)
|
(14)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
17
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
(3)
|
0
|
(3)
|
0
|
|
| Pre-Tax Income |
63
N/A
|
70
+11%
|
62
-11%
|
62
+1%
|
58
-7%
|
66
+14%
|
72
+10%
|
74
+3%
|
86
+16%
|
72
-16%
|
70
-4%
|
63
-10%
|
52
-17%
|
45
-13%
|
35
-22%
|
32
-10%
|
29
-8%
|
32
+10%
|
34
+5%
|
38
+12%
|
38
0%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(15)
|
(16)
|
(10)
|
(10)
|
(8)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(9)
|
(9)
|
(9)
|
(7)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
|
| Income from Continuing Operations |
48
|
54
|
52
|
53
|
50
|
60
|
65
|
68
|
79
|
65
|
61
|
54
|
43
|
38
|
31
|
28
|
25
|
27
|
29
|
32
|
31
|
|
| Net Income (Common) |
56
N/A
|
62
+10%
|
52
-16%
|
53
+2%
|
50
-5%
|
60
+21%
|
65
+8%
|
68
+4%
|
79
+17%
|
65
-18%
|
61
-7%
|
54
-11%
|
43
-20%
|
38
-11%
|
31
-20%
|
28
-10%
|
25
-8%
|
27
+7%
|
29
+7%
|
32
+9%
|
31
-2%
|
|
| EPS (Diluted) |
0.14
N/A
|
0.15
+7%
|
0.13
-13%
|
0.13
N/A
|
0.13
N/A
|
0.15
+15%
|
0.18
+20%
|
0.17
-6%
|
0.2
+18%
|
0.16
-20%
|
0.15
-6%
|
0.13
-13%
|
0.11
-15%
|
0.1
-9%
|
0.08
-20%
|
0.07
-12%
|
0.07
N/A
|
0.08
+14%
|
0.07
-12%
|
0.09
+29%
|
0.08
-11%
|
|